Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary

British Journal of Cancer

Volumn 105, Issue 4, 2011, Pages 493-497

  Mahdi, H ^a   Swensen, R E ^a   Hanna, R ^b   Kumar, S ^c   Ali Fehmi, R ^d   Semaan, A ^d   Tamimi, H ^a   Morris, R T ^d   Munkarah, A R ^e  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c MAYO CLINIC   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

clinical stage I; Lymphadenectomy; malignant germ cell tumour; ovary; survival

Indexed keywords

ADULT; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; EARLY CANCER; FEMALE; GERM CELL TUMOR; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY GERM CELL TUMOR; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES;

EID: 80051580395     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.267     Document Type: Article

References (30)

1. ACOG (2002) The role of generalist obstetrician-gynecologist in the early detection of ovarian cancer. ACOG Committee Opinion No. 280. American College of Obstetricians and Gynecologists. Obstet Gynecol 100: 1413-1416
2. Billmire D, Vinocur C, Rescorla F, Cushing B, London W, Schlatter M, Davis M, Giller R, Lauer S, Olson T (2004) Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. J Pediatr Surg 39(3): 424-429; discussion (Pubitemid 38338361)
3. Brown J, Sood AK, Deavers MT, Milojevic L, Gershenson DM (2009) Patterns of metastasis in sex cord-stromal tumors of the ovary: can routine staging lymphadenectomy be omitted? Gynecol Oncol 113(1): 86-90
4. Cass I, Li AJ, Runowicz CD, Fields AL, Goldberg GL, Leuchter RS, Lagasse LD, Karlan BY (2001) Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas. Gynecol Oncol 80(1): 56-61 (Pubitemid 32062089)
5. Chan JK, Munro EG, Cheung MK, Husain A, Teng NN, Berek JS, Osann K (2007) Association of lymphadenectomy and survival in stage I ovarian cancer patients. Obstet Gynecol 109(1): 12-19 (Pubitemid 46043192)
6. Chan JK, Zhang M, Hu JM, Shin JY, Osann K, Kapp DS (2008) Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States. J Surg Oncol 97(2): 103-107 (Pubitemid 351169035)
7. Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL (2002) Use of SEER-Medicare data for measuring cancer surgery. Med Care 40(8 Suppl): IV-43-48
8. Dimopoulos MA, Papadimitriou C, Hamilos G, Efstathiou E, Vlahos G, Rodolakis A, Aravantinos G, Kalofonos H, Kouroussis C, Gika D, Skarlos D, Bamias A (2004) Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study. Gynecol Oncol 95(3): 695-700 (Pubitemid 39592540)
9. Gershenson DM (1994) Management of early ovarian cancer: germ cell and sex cord-stromal tumors. Gynecol Oncol 55(3 Pt 2): S62-S72
10. Gershenson DM (2007) Management of ovarian germ cell tumors. J Clin Oncol 25(20): 2938-2943 (Pubitemid 47123158)
11. Gershenson DM, Morris M, Cangir A, Kavanagh JJ, Stringer CA, Edwards CL, Silva EG, Wharton JT (1990) Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol 8(4): 715-720 (Pubitemid 20127256)
12. Hankey BF, Ries LA, Edwards BK (1999) The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev 8(12): 1117-1121 (Pubitemid 30004912)
13. Koonings PP, Campbell K, Mishell Jr DR, Grimes DA (1989) Relative frequency of primary ovarian neoplasms: a 10-year review. Obstet Gynecol 74(6): 921-926 (Pubitemid 20003288)
14. Kumar S, Shah JP, Bryant CS, Imudia AN, Cote ML, Ali-Fehmi R, Malone Jr JM, Morris RT (2008) The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary. Gynecol Oncol 110(2): 125-132
15. Kurman RJ, Norris HJ (1977) Malignant germ cell tumors of the ovary. Hum Pathol 8(5): 551-564 (Pubitemid 8216852)
16. Morice P, Joulie F, Camatte S, Atallah D, Rouzier R, Pautier P, Pomel C, Lhomme C, Duvillard P, Castaigne D (2003) Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg 197(2): 198-205 (Pubitemid 36927382)
17. Panici PB, Maggioni A, Hacker N, Landoni F, Ackermann S, Campagnutta E, Tamussino K, Winter R, Pellegrino A, Greggi S, Angioli R, Manci N, Scambia G, Dell'Anna T, Fossati R, Floriani I, Rossi RS, Grassi R, Favalli G, Raspagliesi F, Giannarelli D, Martella L, Mangioni C (2005) Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst 97(8): 560-566 (Pubitemid 40723783)
18. Parham G, Phillips JL, Hicks ML, Andrews N, Jones WB, Shingleton HM, Menck HR (1997) The National Cancer Data Base report on malignant epithelial ovarian carcinoma in African-American women. Cancer 80(4): 816-826 (Pubitemid 27339838)
19. Peccatori F, Bonazzi C, Chiari S, Landoni F, Colombo N, Mangioni C (1995) Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients. Obstet Gynecol 86(3): 367-372
20. Pectasides D, Pectasides E, Kassanos D (2008) Germ cell tumors of the ovary. Cancer Treat Rev 34(5): 427-441
21. Petru E, Lahousen M, Tamussino K, Pickel H, Stranzl H, Stettner H, Winter R (1994) Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 170(2): 656-662 (Pubitemid 24089032)
22. Rogers PC, Olson TA, Cullen JW, Billmire DF, Marina N, Rescorla F, Davis MM, London WB, Lauer SJ, Giller RH, Cushing B (2004) Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study-Pediatric Oncology Group 9048 and Children's Cancer Group 8891. J Clin Oncol 22(17): 3563-3569 (Pubitemid 41103663)
23. Rouzier R, Bergzoll C, Brun JL, Dubernard G, Selle F, Uzan S, Pomel C, Darai E (2010) The role of lymph node resection in ovarian cancer: analysis of the surveillance, epidemiology, and end results (SEER) database. BJOG 17(12): 1451-1458
24. Schlatter M, Rescorla F, Giller R, Cushing B, Vinocur C, Colombani P, Cullen J, London W, Davis M, Lauer S, Olson T (2003) Excellent outcome in patients with stage I germ cell tumors of the testes: a study of the Children's Cancer Group/Pediatric Oncology Group. J Pediatr Surg 38(3): 319-324; discussion (Pubitemid 36278686)
25. Schmeler KM, Tao X, Frumovitz M, Deavers MT, Sun CC, Sood AK, Brown J, Gershenson DM, Ramirez PT (2010) Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary. Obstet Gynecol 116(2 Pt 1): 269-273
26. Scully RE, Sobin LH (1999) Histological Typing of Ovarian Tumors: World Health Organization International Histological Classification of Tumors (ed 2). Springer: Berlin, Germany
27. Serov SF, Scully RE, Sobin LH (1973) Histological Typing of Ovarian Tumors: International Histological Classification of Tumours, No. 9. World Health Organization: Geneva
28. Surveillance E, and End Results (SEER) Program (http://www.seer. cancer.gov) SEER*Stat Database: Incidence-SEER 17 Regs Limited-Use + Hurricane Katrina Impacted Louisiana Cases, Nov 2008 Sub (1973-2006 varying)-Linked To County Attributes-Total US, 1969-2006 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2008 submission
29. Virnig BA, Warren JL, Cooper GS, Klabunde CN, Schussler N, Freeman J (2002) Studying radiation therapy using SEER-Medicare-linked data. Med Care 40(8 Suppl): IV-49-54
30. Williams S, Blessing JA, Liao SY, Ball H, Hanjani P (1994) Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. J Clin Oncol 12(4): 701-706 (Pubitemid 24110908)